Classification: Programmed death ligand-1 (PD-L1) blocking antibody
Your immune system works by making antibodies, which are proteins that attach to antigens found on the surface of a cell. The antibody “calls” your immune system to attack the cell it is attached to, causing your immune system to kill the cell. Monoclonal antibodies are created in a lab to attach to the antigens found on certain types of cancer cells. These antibodies can work in different ways, including stimulating (revving up) the immune system to kill the cell or by blocking cell growth and other functions needed for cell growth.
Cosibelimab-ipdl is a type of monoclonal antibody therapy that targets and blocks PD-L1, a protein found on some cancer cells, from interacting with PD-1 on immune cells. By blocking PD-L1, the immune system can attack and kill the cancer cells, slowing or stopping cancer growth.
Cosibelimab-ipdl is given intravenously (IV, into a vein). Your dose and how often you receive the medication will be determined by your provider. Most often, you will receive this medication over 1 hour every 3 weeks.
Tell your care team about all your medical conditions, including those that are autoimmune in nature (Crohn’s disease, Lupus, rheumatoid arthritis, etc.) as these can get worse with immunotherapy. You should also tell your provider if you have had or plan on having a solid organ transplant, an allogeneic hematopoietic stem cell transplantation (HSCT), or any other surgery or condition that would lead to prolonged or lifelong use of immunosuppression.
Tell your provider if you have had radiation therapy to your chest area or if you have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome.
Make sure your care team is aware of all medications (including prescription and over-the-counter), supplements, and vitamins you are taking. Steroids should be avoided while on immunotherapy unless directed by your care team.
There are a number of things you can do to manage the side effects of cosibelimab-ipdl. Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
This medication stimulates your immune system. Your immune system can attack normal organs and tissues in your body, leading to serious or life-threatening complications. It is important to notify your healthcare provider right away if you develop any of the following symptoms:
Your red blood cells are responsible for carrying oxygen to the tissues in your body. When the red cell count is low, you may feel tired or weak. You should let your oncology care team know if you experience any shortness of breath, difficulty breathing, or pain in your chest. If the count gets too low, you may receive a blood transfusion.
White blood cells (WBC) are important for fighting infection. While receiving treatment, your WBC count can drop, putting you at a higher risk of getting an infection. You should let your doctor or nurse know right away if you have a fever (temperature greater than 100.4°F or 38°C), sore throat or cold, shortness of breath, cough, burning with urination, or a sore that doesn't heal.
Tips to preventing infection:
Platelets help your blood clot, so when the count is low you are at a higher risk of bleeding. Let your oncology care team know if you have any excess bruising or bleeding, including nose bleeds, bleeding gums or blood in your urine or stool. If the platelet count becomes too low, you may receive a transfusion of platelets.
This medication can affect the normal levels of electrolytes (sodium, potassium, calcium, etc.) in your body. Your levels will be monitored using blood tests. If your levels become too low, your care team may prescribe specific electrolytes to be given by IV or taken by mouth. Do not take any supplements without first consulting with your care team.
Fatigue is very common during cancer treatment and is an overwhelming feeling of exhaustion that is not usually relieved by rest. While on cancer treatment, and for a period after, you may need to adjust your schedule to manage fatigue. Plan times to rest during the day and conserve energy for more important activities. Exercise can help combat fatigue; a simple daily walk with a friend can help. Talk to your healthcare team for helpful tips on dealing with this side effect.
Your healthcare provider can recommend medications and other strategies to help relieve pain.
Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication. Effective birth control for women is necessary during treatment and for at least 4 months after your last treatment, even if your menstrual cycle stops. Men should talk with their provider about birth control during and after treatment. You may want to consider sperm banking or egg harvesting if you may wish to have a child in the future. Discuss these options with your oncology team. You should not breastfeed while taking this medication and for 4 months after the last dose.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania